-
EP1206471
European procedure
Extract from the Register of European Patents
EP About this file: EP1206471
| EP1206471 - INTERLEUKIN-5 INHIBITING 6-AZAURACIL DERIVATIVES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.01.2007 Database last updated on 12.07.2024 | Most recent event Tooltip | 12.12.2008 | Lapse of the patent in a contracting state New state(s): CY | published on 14.01.2009 [2009/03] | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
| Former [2002/21] | For all designated states JANSSEN PHARMACEUTICA N.V. Turnhoutsebaan 30 2340 Beerse / BE | Inventor(s) | 01 /
LACRAMPE, Jean Fernand Armand, Janssen Cilag S.A. 11, rue Camille Desmoulins, TSA 91003 92787 Issy-les-Moulineaux Cedex 9 / FR | 02 /
FREYNE, Eddy Jean Edgard Janssen Pharmaceutica N.V., Turnhoutseweg 30 2340 Beerse / BE | 03 /
DEROOSE, Frederik Dirk Janssen Pharmaceutica N.V., Turnhoutseweg 30 2340 Beerse / BE | 04 /
FORTIN, Jérôme Michel Claude, Janssen Cilag S.A. 1, rue Camille Desmoulins, TSA 91003 92787 Issy-les-Moulineaux Cedex 9 / FR | 05 /
COESEMANS, Erwin Janssen Pharmaceutica N.V., Turnhoutseweg 30 2340 Beerse / BE | [2002/21] | Application number, filing date | 00948015.3 | 31.07.2000 | [2002/21] | WO2000EP07358 | Priority number, date | EP19990870170 | 06.08.1999 Original published format: EP 99870170 | EP19990126035 | 27.12.1999 Original published format: EP 99126035 | [2002/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0110866 | Date: | 15.02.2001 | Language: | EN | [2001/07] | Type: | A1 Application with search report | No.: | EP1206471 | Date: | 22.05.2002 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.02.2001 takes the place of the publication of the European patent application. | [2002/21] | Type: | B1 Patent specification | No.: | EP1206471 | Date: | 01.03.2006 | Language: | EN | [2006/09] | Search report(s) | International search report - published on: | EP | 15.02.2001 | Classification | IPC: | C07D417/10, C07D417/14, C07D413/10, A61K31/53, A61P11/06 | [2002/21] | CPC: |
A61K51/0491 (EP,KR,US);
A61K51/0461 (EP,KR,US);
A61K51/0463 (EP,KR,US);
A61K51/0468 (EP,KR,US);
A61P1/02 (EP);
A61P1/04 (EP);
A61P11/06 (EP);
A61P11/08 (EP);
A61P15/02 (EP);
A61P17/06 (EP);
A61P27/02 (EP);
A61P27/16 (EP);
A61P37/00 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/21] | Extension states | AL | 06.03.2002 | LT | 06.03.2002 | LV | 06.03.2002 | MK | 06.03.2002 | RO | 06.03.2002 | SI | 06.03.2002 | Title | German: | INTERLEUKIN-5 HEMMENDE 6-AZAURACIL DERIVATE | [2002/21] | English: | INTERLEUKIN-5 INHIBITING 6-AZAURACIL DERIVATIVES | [2002/21] | French: | DERIVES DE 6-AZAURACILE INHIBANT L'INTERLEUKINE 5 | [2002/21] | Entry into regional phase | 06.03.2002 | National basic fee paid | 06.03.2002 | Designation fee(s) paid | 06.03.2002 | Examination fee paid | Examination procedure | 18.12.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 06.03.2002 | Examination requested [2002/21] | 04.07.2002 | Despatch of a communication from the examining division (Time limit: M06) | 10.01.2003 | Reply to a communication from the examining division | 28.02.2003 | Despatch of a communication from the examining division (Time limit: M06) | 25.08.2003 | Reply to a communication from the examining division | 11.12.2003 | Despatch of a communication from the examining division (Time limit: M04) | 27.02.2004 | Reply to a communication from the examining division | 11.02.2005 | Despatch of a communication from the examining division (Time limit: M02) | 24.02.2005 | Reply to a communication from the examining division | 22.04.2005 | Communication of intention to grant the patent | 02.09.2005 | Fee for grant paid | 02.09.2005 | Fee for publishing/printing paid | 23.11.2005 | Despatch of a communication from the examining division (Time limit: M01) | 06.12.2005 | Reply to a communication from the examining division | Opposition(s) | 04.12.2006 | No opposition filed within time limit [2007/06] | Fees paid | Renewal fee | 31.07.2002 | Renewal fee patent year 03 | 31.07.2003 | Renewal fee patent year 04 | 02.08.2004 | Renewal fee patent year 05 | 01.08.2005 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 01.03.2006 | FI | 01.03.2006 | DK | 01.06.2006 | SE | 01.06.2006 | GR | 02.06.2006 | PT | 01.08.2006 | [2009/03] |
| Former [2008/19] | FI | 01.03.2006 | |
| DK | 01.06.2006 | ||
| SE | 01.06.2006 | ||
| GR | 02.06.2006 | ||
| PT | 01.08.2006 | ||
| Former [2007/45] | FI | 01.03.2006 | |
| DK | 01.06.2006 | ||
| SE | 01.06.2006 | ||
| PT | 01.08.2006 | ||
| Former [2007/35] | FI | 01.03.2006 | |
| IT | 01.03.2006 | ||
| DK | 01.06.2006 | ||
| SE | 01.06.2006 | ||
| PT | 01.08.2006 | ||
| Former [2007/09] | FI | 01.03.2006 | |
| DK | 01.06.2006 | ||
| SE | 01.06.2006 | ||
| PT | 01.08.2006 | ||
| Former [2007/08] | FI | 01.03.2006 | |
| DK | 01.06.2006 | ||
| SE | 01.06.2006 | ||
| Former [2006/46] | FI | 01.03.2006 | |
| SE | 01.06.2006 | ||
| Former [2006/36] | FI | 01.03.2006 | Cited in | International search | [X]FR2532313 (ROUSSEL UCLAF [FR]) [X] 20 * page 28, line 9 - line 16 ** page 32, line 14 - line 21 *; | [A]WO9902504 (JANSSEN PHARMACEUTICA NV [BE], et al) [A] 1,11,13,14,16,17 * the whole document *; | [AD]WO9902505 (JANSSEN PHARMACEUTICA NV [BE], et al) [AD] 1,11,13,14,16,17 * the whole document * |